Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: E9B1C0
Term | Name | Level | Count |
---|---|---|---|
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008380 | RNA splicing | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000213 | tRNA-intron endonuclease activity | 6 | 1 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004519 | endonuclease activity | 5 | 1 |
GO:0004521 | RNA endonuclease activity | 5 | 1 |
GO:0004540 | RNA nuclease activity | 4 | 1 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 1 |
GO:0005488 | binding | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 6 | 1 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.466 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.467 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.534 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.467 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.699 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.409 |
DOC_CYCLIN_RxL_1 | 39 | 46 | PF00134 | 0.263 |
DOC_PP4_FxxP_1 | 102 | 105 | PF00568 | 0.622 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.736 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.364 |
DOC_USP7_MATH_2 | 13 | 19 | PF00917 | 0.558 |
DOC_WW_Pin1_4 | 101 | 106 | PF00397 | 0.429 |
DOC_WW_Pin1_4 | 50 | 55 | PF00397 | 0.552 |
LIG_14-3-3_CanoR_1 | 116 | 126 | PF00244 | 0.358 |
LIG_14-3-3_CanoR_1 | 42 | 48 | PF00244 | 0.285 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.336 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.430 |
LIG_FHA_2 | 128 | 134 | PF00498 | 0.280 |
LIG_LIR_Apic_2 | 100 | 105 | PF02991 | 0.618 |
LIG_LIR_Gen_1 | 3 | 9 | PF02991 | 0.701 |
LIG_LIR_Nem_3 | 3 | 7 | PF02991 | 0.664 |
LIG_NRBOX | 39 | 45 | PF00104 | 0.352 |
LIG_SH2_STAP1 | 139 | 143 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.437 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.670 |
LIG_SUMO_SIM_anti_2 | 107 | 113 | PF11976 | 0.441 |
LIG_SUMO_SIM_anti_2 | 3 | 9 | PF11976 | 0.573 |
MOD_CDC14_SPxK_1 | 53 | 56 | PF00782 | 0.450 |
MOD_CDK_SPxK_1 | 50 | 56 | PF00069 | 0.454 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.483 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.409 |
MOD_CK2_1 | 127 | 133 | PF00069 | 0.273 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.418 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.448 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.604 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.537 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.427 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.682 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.638 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.571 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.493 |
MOD_N-GLC_2 | 119 | 121 | PF02516 | 0.423 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.321 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.399 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.484 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.585 |
MOD_OFUCOSY | 115 | 121 | PF10250 | 0.353 |
MOD_PKA_1 | 122 | 128 | PF00069 | 0.408 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.509 |
MOD_Plk_2-3 | 15 | 21 | PF00069 | 0.528 |
MOD_Plk_2-3 | 83 | 89 | PF00069 | 0.452 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.437 |
MOD_Plk_4 | 122 | 128 | PF00069 | 0.436 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.700 |
MOD_ProDKin_1 | 101 | 107 | PF00069 | 0.424 |
MOD_ProDKin_1 | 50 | 56 | PF00069 | 0.548 |
TRG_DiLeu_BaLyEn_6 | 39 | 44 | PF01217 | 0.256 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.686 |
TRG_ER_diArg_1 | 72 | 74 | PF00400 | 0.349 |
TRG_ER_diArg_1 | 9 | 12 | PF00400 | 0.528 |
TRG_NLS_MonoExtC_3 | 9 | 14 | PF00514 | 0.577 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4G2 | Leptomonas seymouri | 55% | 91% |
A0A3S7X3W7 | Leishmania donovani | 93% | 100% |
A4HIT3 | Leishmania braziliensis | 80% | 100% |
A4I635 | Leishmania infantum | 93% | 100% |
C9ZRF4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 89% |
Q4Q6U4 | Leishmania major | 90% | 100% |